Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal

Fertility and Sterility

Volumn 87, Issue 5, 2007, Pages 1131-1138

  Cooper, Brian C ^a   Sites, Cynthia K ^a   Casson, Peter R ^a   Toth, Michael J ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

estrogen; GnRH agonist; insulin sensitivity; Ovarian hormones

Indexed keywords

GLUCOSE; GONADORELIN AGONIST; INSULIN; LEUPRORELIN; PLACEBO;

ADULT; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FOLLICULAR PHASE; GLUCONEOGENESIS; GLUCOSE ASSAY; HORMONE SYNTHESIS; HUMAN; HYPERINSULINEMIA; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; OUTCOME ASSESSMENT; OXIDATION; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; TREATMENT DURATION;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INSULIN; LEUPROLIDE; MENSTRUAL CYCLE; OVARY; SINGLE-BLIND METHOD;

EID: 34247464711     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.045     Document Type: Article

References (52)

1. Rowe J.R., Minaker K.D., Pallotta J.A., and Flier J.S. Characterization of the insulin resistance of aging. J Clin Invest 71 (1983) 1581-1587
2. Defronzo R.A. Glucose intolerance and aging. Evidence for tissue insensitivity to insulin. Diabetes 28 (1979) 1095-1101
3. Wu S.I., Chou P., and Tsai S.T. The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 54 (2001) 117-120
4. Godsland I.F. Influence of female sex steroids on glucose metabolism and insulin action: human studies. J Intern Med 240 (1996) 25-49
5. Puah J.A., and Bailey C.J. Effect of ovarian hormones on glucose metabolism in mouse soleus muscle. Endocrinol 117 (1985) 1336-1340
6. Ahmed-Sorour H., and Bailey C.J. Role of ovarian hormones in the long-term control of glucose homeostasis. Hormone Res 13 (1980) 396-403
7. Kumagai S., Holmang A., and Björntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 149 (1993) 91-97
8. Rincon J., Holmang A., Wahlstrom E.O., Lonnroth P., Björntorp P., Zierath J.R., et al. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45 (1996) 615-621
9. Toth M.J., Sites C.K., Eltabbakh G.H., and Poehlman E.T. Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care 23 (2000) 801-806
10. Walton C., Godsland I.F., Proudler A.J., Wynn V., and Stevenson J.C. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 23 (1993) 466-473
11. Proudler A.J., Felton C.V., and Stevenson J.C. Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women. Clin Sci 83 (1992) 489-494
12. O'Sullivan A.J., and Ho K.K.Y. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 80 (1995) 1783-1788
13. Cagnacci A., Soldani R., Carriero P.L., Paoletti A.M., Fioretti P., and Melis G.B. Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74 (1992) 1396-40
14. Lasco A., Alvaro S., Frisina N., Di Benedetto A., Denuzzo G., and Cucinotta D. Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women. Diabetes Care 23 (2000) 422-424
15. Duncan A.C., Lyall H., Roberts R.N., Petrie J.R., Perera M.J., Monaghan S., et al. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. J Clin Endocrinol Metab 84 (1999) 2402-2407
16. Cucinelli F., Paparella P., Soranna L., Barini A., Cinque B., Mancuso S., et al. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol 140 (1999) 215-223
17. Mattiasson I., Rendell M., Tornquist C., Jeppsson S., and Hulthen U.L. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women. Horm Metab Res 34 (2002) 583-588
18. Walker R.J., Lewis-Barned N.J., Sutherland W.H., Goulding A., Edwards E.A., deJong S.A., et al. The effects of sequential combined oral 17β-estradiol and norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. Menopause 8 (2001) 27-32
19. Kimmerle R., Heinemann L., Heise T., Bender R., Weyer C., Hirshberger S., et al. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Menopause 6 (1999) 36-42
20. Sites C.K., L'Hommedieu G.D., Toth M.J., Brochu M., Cooper B.C., and Fairhurst P.A. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90 (2005) 2701-2707
21. Beckett T., Tchernof A., and Toth M.J. Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats. Metabolism 51 (2002) 1397-1401
22. Toth M.J., Sites C.K., Matthews D.E., and Casson P.R. Ovarian suppression with gonadotropin-releasing hormone agonist reduces whole body protein turnover in women. Am J Physiol 291 (2006) E483-E490
23. Cooper B.C., Sites C.K., Fairhurst P.A., and Toth M.J. Evidence against a role for ovarian hormones in the regulation of blood flow. Fertil Steril 86 (2006) 440-447
24. Abumrad N.N., Rabin D., Diamond M.P., and Lacy W.W. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metab Clin Exp 20 (1981) 936-940
25. Toth M.J., Tchernof A., Rosen C.J., Matthews D.E., and Poehlman E.T. Regulation of protein metabolism in middle-aged, premenopausal women: roles of adiposity and estradiol. J Clin Endocrinol Metab 85 (2000) 1382-1387
26. Toth M.J., Sites C.K., Cefalu W.T., Matthews D.E., and Poehlman E.T. Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women. Am J Physiol Endocrinol Metab 281 (2001) E113-E121
27. Diamond M.P., Jacob R., Connolly-Diamond M., and DeFronzo R.A. Glucose metabolism during the menstrual cycle. Assessment with the euglycemic, hyperinsulinemic clamp. J Reprod Med 38 (1993) 417-421
28. Dumesic D.A., Nielsen M.F., Abbott D.H., Eisner J.R., Nair K.S., and Rizza R.A. Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women. Fertil Steril 72 (1999) 458-466
29. Allsop J.R., Wolfe R.R., and Burke J.F. Tracer priming the bicarbonate pool. J Appl Physiol 45 (1978) 137-139
30. 2 enrichment. J Appl Physiol 56 (1984) 230-234
31. 2 breath tests. Am J Clin Nutr 33 (1980) 2375-2385
32. Simonson D.C., and DeFronzo R.A. Indirect calorimetry: methodological and interpretative problems. Am J Physiol Endocrinol Metab 258 (1990) E399-E412
33. Glickman S.G., Marn C.S., Supiano M.A., and Dengel D.R. Validity and reliability of dual-energy x-ray absorptiometry for the assessment of abdominal adiposity. J Appl Physiol 97 (2004) 509-514
34. Ross R., Freeman J., Hudson R., and Janssen I. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 87 (2002) 5044-5051
35. Abate N., Haffner S.M., Garg A., Peshock R.M., and Grundy S.M. Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 87 (2002) 4522-4527
36. Toth E.L., Suthijumroon A., Crockford P.M., and Ryan E.A. Insulin action does not change during the menstrual cycle in normal women. J Clin Endocrinol Metab 64 (1987) 74-80
37. Yki-Jarvinen H. Insulin sensitivity during the menstrual cycle. J Clin Endocrinol Metab 59 (1984) 350-353
38. Richard D. Effect of ovarian hormones on energy balance and brown adipose tissue thermogenesis. Am J Physiol Renal Physiol 250 (1986) R245-R249
39. Chen Y., and Heiman M.L. Increased weight gain after ovariectomy is not a consequence of leptin resistance. Am J Physiol Endocrinol Metab 280 (2001) E315-E322
40. Banerjee S., Saenger P., Hu M., Chen W., and Barzilai N. Fat accretion and the regulation of insulin-mediated glycogen synthesis after puberty in rats. Am J Physiol Renal Physiol 273 (1997) R1534-R1539
41. Toth M.J., Tchernof A., Sites C.K., and Poehlman E.T. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes 24 (2000) 226-231
42. Tchernof A., Desmeules A., Richard C., LaBerge P., Daris M., Mailloux J., et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab 89 (2004) 3425-3430
43. Ferrannini E., Vichi S., Beck-Nielsen H., Laasku M., Paolisso G., Smith U., and European Group for the Study of Insulin Resistance (EGIR). Insulin action and age. Diabetes 45 (1996) 947-953
44. Kohrt W.M., Kirwan J.P., Staten M.A., Bourey R.E., King D.S., and Holloszy J.O. Insulin resistance in aging is related to abdominal obesity. Diabetes 42 (1993) 273-281
45. Basu R., Breda E., Oberg A.L., Powell C.C., Man C.D., Basu A., et al. Mechanisms of the age-associated deterioration in glucose tolerance. Contribution of alterations in insulin secretion, action and clearance. Diabetes 52 (2003) 1738-1748
46. Krebs M., Krssak M., Bernroider E., Anderwald C., Brehm A., Meyerspeer M., et al. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51 (2002) 599-605
47. Pisters P.W.T., Restifo N.P., Cersosimo E., and Brennan M.F. The effects of euglycemic hyperinsulinemia and amino acid infusion on regional and whole body glucose disposal in man. Metab Clin Exp 40 (1991) 59-65
48. Buckspan R., Hoxworth B., Cersosimo E., Devlin J.T., Horton E., and Abumrad N. alpha-Ketoisocaproate is superior to leucine in sparing glucose utilization in humans. Am J Physiol Endocrinol Metab 251 (1986) E648-E653
49. Boden G., and Tappy L. Effects of amino acids on glucose disposal. Diabetes 39 (1990) 1079-1084
50. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97 (1997) 2859-2865
51. Frias J.P., Macaraeg G.B., Ofrecio J., Yu J.G., Olefsky J.M., and Kruszynska Y.T. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 50 (2001) 1344-1350
52. Perseghin G., Scifo P., Pagliato E., Battezzati A., Benedini S., Soldini L., et al. Gender factors affect fatty acids-induced insulin resistance in non-obese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab 86 (2001) 3188-3196